Package 65862-710-60

{"route": ["ORAL"], "spl_id": "8f8c56e0-40ee-4643-88f7-d3571ff5a409", "openfda": {"unii": ["4MT4VIE29P"], "rxcui": ["402245", "402246", "402247", "664741"], "spl_set_id": ["7fbea274-d6b5-4faa-bbf0-05fefab42114"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (65862-710-03)  / 10 CAPSULE in 1 BLISTER PACK (65862-710-10)", "package_ndc": "65862-710-03", "marketing_start_date": "20180625"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-710-05)", "package_ndc": "65862-710-05", "marketing_start_date": "20180625"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (65862-710-60)", "package_ndc": "65862-710-60", "marketing_start_date": "20180625"}], "brand_name": "Atazanavir Sulfate", "product_id": "65862-710_8f8c56e0-40ee-4643-88f7-d3571ff5a409", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "65862-710", "generic_name": "Atazanavir", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atazanavir Sulfate", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "100 mg/1"}], "application_number": "ANDA204806", "marketing_category": "ANDA", "marketing_start_date": "20180625", "listing_expiration_date": "20261231"}